• Overview
    Overview
  • Revenue
    Revenue
  • Segments
    • Revenue by Product
    • Revenue by Region
    Segments
  • Financials
    • Income Statement
    • Balance Sheet
    • Cashflow Statements
    • Profitability
    • Ratios
    Financials
  • People
    • CEO Salary
    • Employees
    • Revenue per Employee
    • Net Income per Employee
    People
  • OwnershipOwnership
    Ownership
  • Competitors
    Competitors
  • Stocks
    • Market Cap
    • PE Ratio
    • Stock Split
    Stocks
  • News
    • Company News
    • Press Releases
    News
  • Earnings Calls
    Earnings Calls
  • Documents
    • Annual Reports
    • Quarterly Reports
    • SEC Filings
    Documents
Submit Feedback
Submit Feedback (Sign in required)
Bullfincher logo
Recent searches
    Trending searches
    • Company logo Caterpillar Overview
    • Company logo Apple Revenue
    • Company logo NVIDIA Corporation Employees
    • Company logo Microsoft Corporati... Revenue by segment
    • Company logo Amazon.com Financials
    • Company logo Tesla Overview
    • Home
    • Companies
    • Calendars
    • Ranking
    • Blog
    • Login

    Submit feedback to Bullfincher

    BSX logo Boston Scientific Corporation +
    BSX logo
    Boston Scientific Corporation
    +
    • Overview
    • Revenue
    • Segments
      • Revenue by Product
      • Revenue by Region
    • Financials
      • Income Statement
      • Balance Sheet
      • Cashflow Statement
      • Profitability
      • Ratios
    • People
      • CEO Salary
      • Employees
      • Revenue per Employee
      • Net Income per Employee
    • Ownership
    • Competitors
    • Stocks
      • Market Cap
      • PE Ratio
      • Stock Split
    • News
      • Company News
      • Press Releases
    • Earnings Calls
    • Documents
      • Annual Report 10K
      • Quarterly Report 10Q
      • SEC Filings
    BSX logo Boston Scientific Corporation BSX + Follow
    • Revenue
    • Employees
    • Market Capitalization

    Boston Scientific Corporation's Revenue (2016 - 2025)

    • Boston Scientific Corporation's annual revenue was $20.07 B in fiscal year 2025. The annual revenue increased $3.33 B from $16.75 B (in 2024) to $20.07 B (in 2025), representing a 19.87% year-over-year growth.

    • Boston Scientific Corporation's quarterly revenue was $5.20 B in the quarter ending Mar 2026. The quarterly revenue increased $540.00 M from $4.66 B (in Q1: Dec 2025) to $5.20 B (in Q1: Dec 2026), representing a 11.58% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
    • The highest annual revenue for Boston Scientific Corporation was $20.07 B in fiscal year 2025.
    • The lowest annual revenue was $8.39 B in fiscal year 2016.
    • The average revenue was $12.35 B.

    • Learn more about Boston Scientific Corporation's Revenue by Segment and Revenue by Region.

      Check out competitors to Boston Scientific Corporation in a side-by-side comparison.

      Explore additional financial metrics for Boston Scientific Corporation.


      Definition of Revenue :
    • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
    Continue reading...

    Boston Scientific Corporation's Revenue Trend

    2015 7477000000.00
    2016 8386000000.00
    2017 9048000000.00
    2018 9823000000.00
    2019 10735000000.00
    2020 9913000000.00
    2021 11888000000.00
    2022 12682000000.00
    2023 14240000000.00
    2024 16747000000.00
    2025 20074000000.00
    Mar 2016 1964000000.00
    Jun 2016 2126000000.00
    Sep 2016 2105000000.00
    Dec 2016 2191000000.00
    Mar 2017 2160000000.00
    Jun 2017 2257000000.00
    Sep 2017 2222000000.00
    Dec 2017 2408000000.00
    Mar 2018 2379000000.00
    Jun 2018 2490000000.00
    Sep 2018 2393000000.00
    Dec 2018 2561000000.00
    Mar 2019 2493000000.00
    Jun 2019 2631000000.00
    Sep 2019 2707000000.00
    Dec 2019 2905000000.00
    Mar 2020 2543000000.00
    Jun 2020 2003000000.00
    Sep 2020 2659000000.00
    Dec 2020 2708000000.00
    Mar 2021 2752000000.00
    Jun 2021 3077000000.00
    Sep 2021 2932000000.00
    Dec 2021 3127000000.00
    Mar 2022 3026000000.00
    Jun 2022 3244000000.00
    Sep 2022 3170000000.00
    Dec 2022 3242000000.00
    Mar 2023 3389000000.00
    Jun 2023 3599000000.00
    Sep 2023 3527000000.00
    Dec 2023 3725000000.00
    Mar 2024 3856000000.00
    Jun 2024 4120000000.00
    Sep 2024 4209000000.00
    Dec 2024 4561000000.00
    Mar 2025 4663000000.00
    Jun 2025 5061000000.00
    Sep 2025 5065000000.00
    Dec 2025 5286000000.00
    Mar 2026 5203000000.00

    2025

    Boston Scientific Corporation's annual revenue was $20.07 B in fiscal year 2025.

    Boston Scientific Corporation's quarterly revenue was $4.66 B(Q1: Mar 2025), $5.06 B(Q2: Jun 2025), $5.07 B(Q3: Sep 2025), $5.29 B(Q4: Dec 2025) in fiscal year 2025.

    2024

    Boston Scientific Corporation's annual revenue was $16.75 B in fiscal year 2024.

    Boston Scientific Corporation's quarterly revenue was $3.86 B(Q1: Mar 2024), $4.12 B(Q2: Jun 2024), $4.21 B(Q3: Sep 2024), $4.56 B(Q4: Dec 2024) in fiscal year 2024.

    2023

    Boston Scientific Corporation's annual revenue was $14.24 B in fiscal year 2023.

    Boston Scientific Corporation's quarterly revenue was $3.39 B(Q1: Mar 2023), $3.60 B(Q2: Jun 2023), $3.53 B(Q3: Sep 2023), $3.73 B(Q4: Dec 2023) in fiscal year 2023.

    2022

    Boston Scientific Corporation's annual revenue was $12.68 B in fiscal year 2022.

    Boston Scientific Corporation's quarterly revenue was $3.03 B(Q1: Mar 2022), $3.24 B(Q2: Jun 2022), $3.17 B(Q3: Sep 2022), $3.24 B(Q4: Dec 2022) in fiscal year 2022.

    2021

    Boston Scientific Corporation's annual revenue was $11.89 B in fiscal year 2021.

    Boston Scientific Corporation's quarterly revenue was $2.75 B(Q1: Mar 2021), $3.08 B(Q2: Jun 2021), $2.93 B(Q3: Sep 2021), $3.13 B(Q4: Dec 2021) in fiscal year 2021.

    2020

    Boston Scientific Corporation's annual revenue was $9.91 B in fiscal year 2020.

    Boston Scientific Corporation's quarterly revenue was $2.54 B(Q1: Mar 2020), $2.00 B(Q2: Jun 2020), $2.66 B(Q3: Sep 2020), $2.71 B(Q4: Dec 2020) in fiscal year 2020.

    2019

    Boston Scientific Corporation's annual revenue was $10.74 B in fiscal year 2019.

    Boston Scientific Corporation's quarterly revenue was $2.49 B(Q1: Mar 2019), $2.63 B(Q2: Jun 2019), $2.71 B(Q3: Sep 2019), $2.91 B(Q4: Dec 2019) in fiscal year 2019.

    2018

    Boston Scientific Corporation's annual revenue was $9.82 B in fiscal year 2018.

    Boston Scientific Corporation's quarterly revenue was $2.38 B(Q1: Mar 2018), $2.49 B(Q2: Jun 2018), $2.39 B(Q3: Sep 2018), $2.56 B(Q4: Dec 2018) in fiscal year 2018.

    2017

    Boston Scientific Corporation's annual revenue was $9.05 B in fiscal year 2017.

    Boston Scientific Corporation's quarterly revenue was $2.16 B(Q1: Mar 2017), $2.26 B(Q2: Jun 2017), $2.22 B(Q3: Sep 2017), $2.41 B(Q4: Dec 2017) in fiscal year 2017.

    2016

    Boston Scientific Corporation's annual revenue was $8.39 B in fiscal year 2016.

    Boston Scientific Corporation's quarterly revenue was $1.96 B(Q1: Mar 2016), $2.13 B(Q2: Jun 2016), $2.11 B(Q3: Sep 2016), $2.19 B(Q4: Dec 2016) in fiscal year 2016.

    Continue reading...

    Boston Scientific Corporation's Revenue (Year-over-Year Change)

    2015 0
    2016 +12.16
    2017 +7.89
    2018 +8.57
    2019 +9.28
    2020 -7.66
    2021 +19.92
    2022 +6.68
    2023 +12.29
    2024 +17.61
    2025 +19.87
    Q1: Mar 16 11.09
    Q2: Jun 16 15.36
    Q3: Sep 16 11.49
    Q4: Dec 16 10.77
    Q1: Mar 17 9.98
    Q2: Jun 17 6.16
    Q3: Sep 17 5.56
    Q4: Dec 17 9.90
    Q1: Mar 18 10.14
    Q2: Jun 18 10.32
    Q3: Sep 18 7.70
    Q4: Dec 18 6.35
    Q1: Mar 19 4.79
    Q2: Jun 19 5.66
    Q3: Sep 19 13.12
    Q4: Dec 19 13.43
    Q1: Mar 20 2.01
    Q2: Jun 20 -23.87
    Q3: Sep 20 -1.77
    Q4: Dec 20 -6.78
    Q1: Mar 21 8.22
    Q2: Jun 21 53.62
    Q3: Sep 21 10.27
    Q4: Dec 21 15.47
    Q1: Mar 22 9.96
    Q2: Jun 22 5.43
    Q3: Sep 22 8.12
    Q4: Dec 22 3.68
    Q1: Mar 23 12.00
    Q2: Jun 23 10.94
    Q3: Sep 23 11.26
    Q4: Dec 23 14.90
    Q1: Mar 24 13.78
    Q2: Jun 24 14.48
    Q3: Sep 24 19.34
    Q4: Dec 24 22.44
    Q1: Mar 25 20.93
    Q2: Jun 25 22.84
    Q3: Sep 25 20.34
    Q4: Dec 25 15.90
    Q1: Mar 26 11.58

    2025

    Boston Scientific Corporation’s annual revenue increased +19.87% during fiscal year 2025 compared to 2024. It represents a growth of $3.33 B from $16.75 B (in 2024) to $20.07 B (in 2025).

    2024

    Boston Scientific Corporation’s annual revenue increased +17.61% during fiscal year 2024 compared to 2023. It represents a growth of $2.51 B from $14.24 B (in 2023) to $16.75 B (in 2024).

    2023

    Boston Scientific Corporation’s annual revenue increased +12.29% during fiscal year 2023 compared to 2022. It represents a growth of $1.56 B from $12.68 B (in 2022) to $14.24 B (in 2023).

    2022

    Boston Scientific Corporation’s annual revenue increased +6.68% during fiscal year 2022 compared to 2021. It represents a growth of $794.00 M from $11.89 B (in 2021) to $12.68 B (in 2022).

    2021

    Boston Scientific Corporation’s annual revenue increased +19.92% during fiscal year 2021 compared to 2020. It represents a growth of $1.98 B from $9.91 B (in 2020) to $11.89 B (in 2021).

    2020

    Boston Scientific Corporation’s annual revenue decreased -7.66% during fiscal year 2020 compared to 2019. It represents a decline of $822.00 M from $10.74 B (in 2019) to $9.91 B (in 2020).

    2019

    Boston Scientific Corporation’s annual revenue increased +9.28% during fiscal year 2019 compared to 2018. It represents a growth of $912.00 M from $9.82 B (in 2018) to $10.74 B (in 2019).

    2018

    Boston Scientific Corporation’s annual revenue increased +8.57% during fiscal year 2018 compared to 2017. It represents a growth of $775.00 M from $9.05 B (in 2017) to $9.82 B (in 2018).

    2017

    Boston Scientific Corporation’s annual revenue increased +7.89% during fiscal year 2017 compared to 2016. It represents a growth of $662.00 M from $8.39 B (in 2016) to $9.05 B (in 2017).

    2016

    Boston Scientific Corporation’s annual revenue increased +12.16% during fiscal year 2016 compared to 2015. It represents a growth of $909.00 M from $7.48 B (in 2015) to $8.39 B (in 2016).

    Continue reading...

    Boston Scientific Corporation Revenue History

    Sign in to download table

    Period Revenue Year-over-Year Change

    Get instant access to data, Sign up for free

    FY 2025
    $20.07 B $3.33 B 19.87%
    Q4: Dec 25 $5.29 B $725.00 M 15.9%
    Q3: Sep 25 $5.07 B $856.00 M 20.34%
    Q2: Jun 25 $5.06 B $941.00 M 22.84%
    Q1: Mar 25 $4.66 B $807.00 M 20.93%

    Get instant access to data, Sign up for free

    FY 2024
    $16.75 B $2.51 B 17.61%
    Q4: Dec 24 $4.56 B $836.00 M 22.44%
    Q3: Sep 24 $4.21 B $682.00 M 19.34%
    Q2: Jun 24 $4.12 B $521.00 M 14.48%
    Q1: Mar 24 $3.86 B $467.00 M 13.78%

    Get instant access to data, Sign up for free

    FY 2023
    $14.24 B $1.56 B 12.29%
    Q4: Dec 23 $3.73 B $483.00 M 14.9%
    Q3: Sep 23 $3.53 B $357.00 M 11.26%
    Q2: Jun 23 $3.60 B $355.00 M 10.94%
    Q1: Mar 23 $3.39 B $363.00 M 12%

    Get instant access to data, Sign up for free

    FY 2022
    $12.68 B $794.00 M 6.68%
    Q4: Dec 22 $3.24 B $115.00 M 3.68%
    Q3: Sep 22 $3.17 B $238.00 M 8.12%
    Q2: Jun 22 $3.24 B $167.00 M 5.43%
    Q1: Mar 22 $3.03 B $274.00 M 9.96%

    Get instant access to data, Sign up for free

    FY 2021
    $11.89 B $1.98 B 19.92%
    Q4: Dec 21 $3.13 B $419.00 M 15.47%
    Q3: Sep 21 $2.93 B $273.00 M 10.27%
    Q2: Jun 21 $3.08 B $1.07 B 53.62%
    Q1: Mar 21 $2.75 B $209.00 M 8.22%

    Get instant access to data, Sign up for free

    FY 2020
    $9.91 B -$822.00 M 7.66%
    Q4: Dec 20 $2.71 B -$197.00 M 6.78%
    Q3: Sep 20 $2.66 B -$48.00 M 1.77%
    Q2: Jun 20 $2.00 B -$628.00 M 23.87%
    Q1: Mar 20 $2.54 B $50.00 M 2.01%

    Get instant access to data, Sign up for free

    FY 2019
    $10.74 B $912.00 M 9.28%
    Q4: Dec 19 $2.91 B $344.00 M 13.43%
    Q3: Sep 19 $2.71 B $314.00 M 13.12%
    Q2: Jun 19 $2.63 B $141.00 M 5.66%
    Q1: Mar 19 $2.49 B $114.00 M 4.79%

    Get instant access to data, Sign up for free

    FY 2018
    $9.82 B $775.00 M 8.57%
    Q4: Dec 18 $2.56 B $153.00 M 6.35%
    Q3: Sep 18 $2.39 B $171.00 M 7.7%
    Q2: Jun 18 $2.49 B $233.00 M 10.32%
    Q1: Mar 18 $2.38 B $219.00 M 10.14%

    Get instant access to data, Sign up for free

    FY 2017
    $9.05 B $662.00 M 7.89%
    Q4: Dec 17 $2.41 B $217.00 M 9.9%
    Q3: Sep 17 $2.22 B $117.00 M 5.56%
    Q2: Jun 17 $2.26 B $131.00 M 6.16%
    Q1: Mar 17 $2.16 B $196.00 M 9.98%

    Get instant access to data, Sign up for free

    FY 2016
    $8.39 B $909.00 M 12.16%
    Q4: Dec 16 $2.19 B $213.00 M 10.77%
    Q3: Sep 16 $2.11 B $217.00 M 11.49%
    Q2: Jun 16 $2.13 B $283.00 M 15.36%
    Q1: Mar 16 $1.96 B $196.00 M 11.09%

    Frequently Asked Questions

    What is the annual revenue of Boston Scientific Corporation?

    In fiscal year 2025, Boston Scientific Corporation's revenue was $20.07 Billion.

    How much did Boston Scientific Corporation's revenue change in the last year?

    Boston Scientific Corporation's revenue increased by +19.87% (+$3.33 Billion) in 2025 compared to 2024.

    What is Boston Scientific Corporation's most recent quarterly revenue?

    In the first quarter (Q1) of 2026, Boston Scientific Corporation reported a revenue of $5.20 Billion.

    What is Boston Scientific Corporation's revenue per share (TTM)?

    Boston Scientific Corporation's revenue per share over the trailing twelve months is $13.88.

    What is Boston Scientific Corporation's revenue per employee?

    In the fiscal year 2025, Boston Scientific Corporation's revenue per employee was $340.24 K.

    What is the annual net income of Boston Scientific Corporation?

    In fiscal year 2025, Boston Scientific Corporation's net income was $2.89 Billion.

    What is Boston Scientific Corporation's biggest product segment, and what is its revenue?

    Cardiovascular is Boston Scientific Corporation's biggest product segment, generating $13.27 Billion in revenue for fiscal year 2025.

    What is Boston Scientific Corporation's net income per employee?

    In the fiscal year 2025, Boston Scientific Corporation's net income per employee was $48.92 K.

    Related

    • A logo Agilent Technologies Revenue
    • LLY logo Eli Lilly and Company Revenue
    • SYK logo Stryker Corporation Revenue
    • JNJ logo Johnson & Johnson Revenue
    • ABBV logo AbbVie Revenue
    • MRK logo Merck & Co. Revenue
    • TMO logo Thermo Fisher Scientific Revenue
    • ABT logo Abbott Laboratories Revenue
    • DHR logo Danaher Corporation Revenue

    People Also Search For

    • CAT logo Caterpillar
    • AAPL logo Apple
    • NVDA logo NVIDIA Corporation
    • MSFT logo Microsoft Corporation
    • AMZN logo Amazon.com
    • TSLA logo Tesla
    • GOOGL logo Alphabet (Google)
    • NKE logo NIKE
    • WMT logo Walmart
    • META logo Meta Platforms (Facebook)
    • PEP logo PepsiCo
    • TGT logo Target Corporation
    footer logo

    Bullfincher is a “visual-first” business intelligence and research platform. We believe that behind every great company, there is a great story. At Bullfincher, we make story-telling a little easier using dynamic visuals, charts, and graphs.

    explore
    • About Us
    • Blog
    • FAQ
    • Glossary
    Discover
    • Privacy Policy
    • Contact us
    • Submit Feedback
    • Advertise with Us
    Subscribe to our Newsletter !

    Don’t worry, we won’t spam you.

    Disclaimers - All data and information is provided “as is” for informational purposes only and is not intended for trading purposes or financial, investment, tax, legal, accounting, or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. Bullfincher is not an investment adviser, financial adviser, or a securities broker.None of the data and information constitutes investment advice nor an offering, recommendation, or solicitation by Bullfincher to buy, sell, or hold any security or financial product, and Bullfincher makes no representation (and has no opinion) regarding the advisability or suitability of any investment.

    None of the data and information constitutes investment advice (whether general or customized). The financial products or operations referred to in such data and information may not be suitable for your investment profile and investment objectives or expectations. It is your responsibility to consider whether any financial product or operation is suitable foryou based on your interests, investment objectives, investment horizon, and risk appetite. Bullfincher shall not be liable for any damages arising from any operations or investments in financial products referred to within. Bullfincher does not recommend using the data and information provided as the only basis for making any investment decision.

    Bullfincher 2026, All rights reserved

    Submit feedback to Bullfincher

    Submit your feedback


    Note: Please upload only jpg and png file and size 5 MB allowed.